Ctn2.5mg9s.jpg (Ctn2.5mg9s.jpg)
Frovatriptan Succinate Tablets are prescription-only tablets made by Glenmark Pharmaceuticals Inc., USA, and are a treatment for migraines. Each tablet contains 3.91 mg of frovatriptan succinate equivalent to 2.5 mg of frovatriptan. The usual dosage is stated in the accompanying Prescribing Information. This unit-dose package is not child-resistant, so it should be kept out of reach of children. The tablets should be stored at temperatures between 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). The product is manufactured in India with the manufacturing license number: 25/9/2010. Contact information is provided for Glenmark Pharmaceuticals Inc., USA, for any questions.*